Cetero Research

 

Today's Research for Tomorrow's Healthcare
 
 
+
+
+
 +
+
 
   
     
 
Complete Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  




  Compound Matrix Sensitivity Methodology
Rabeprazole Plasma 2.00 ng/mL LC/MS/MS
Raloxifene Plasma 20.0 pg/mL LC/MS/MS
Raloxifene 6 and 4’-Glucuronide Plasma 0.500/4.00 ng/mL LC/MS/MS
Ramipril / Ramiprilat Plasma 0.0500 / 0.100 ng/mL LC/MS/MS
Ranitidine Plasma 20.0 ng/mL LC/MS/MS
Repaglinide Plasma 0.250 ng/mL LC/MS/MS
Rhein Plasma 20.0 ng/mL LC/MS/MS
Ribavirin (Low Range) Plasma 1.00 ng/mL LC/MS/MS
Rimantadine Plasma 5.00 ng/mL HPLC
Risedronate Serum 0.2 ng/mL LC/MS/MS
Risperidone / 9-Hydroxyrisperidone Plasma 0.0500 / 0.0500 ng/mL LC/MS/MS
Ritalinic Acid Plasma 20.0 ng/mL LC/MS/MS
Ritodrine Plasma 0.500 ng/mL HPLC
Rizatriptan Plasma 0.200 ng/mL LC/MS/MS
Ropinirole Plasma 20.0 pg/mL LC/MS/MS
Rosiglitazone Plasma 2.00 ng/mL LC/MS/MS
Rosuvastatin Plasma 0.500 ng/mL LC/MS/MS


 
 
 
|
|
|
|
|
|
 
Copyright © 2009 CRS Management. All rights reserved.
 
Developed by Web Interactive Technologies Baltimore Web Design